Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa
- PMID: 31729595
- DOI: 10.1007/s00403-019-02014-8
Serum amyloid A and C-reactive protein levels and erythrocyte sedimentation rate are important indicators in hidradenitis suppurativa
Abstract
Hidradenitis suppurativa (HS) is a chronic disabling inflammatory disease of the follicular unit especially affecting apocrine gland-bearing skin areas. Little is known about systemic inflammatory complications of the disease. This study aimed to evaluate systemic inflammation in patients with HS by assessing serum amyloid A protein (SAA) and C-reactive protein (CRP) levels and erythrocyte sedimentation rate (ESR) and to identify potential risk factors for HS. Forty-four patients (M/F: 28/16) and 44 age- and sex-matched controls (M/F: 28/16) were enrolled. Demographic, clinical, laboratory, and therapeutic data, including smoking status, body mass index (BMI), waist circumference (WC), serum fasting lipid profile, fasting blood glucose, SAA, and CRP levels, and ESR were assessed. Associations were investigated by univariate and multivariate analyses. Patients with HS showed significantly higher levels of pack-years of cigarette smoking, weight, BMI, and WC (P = 0.01, P < 0.001, P = 0.001) and elevated SAA and CRP levels and ESR (P = 0.008, P = 0.01 and P < 0.001). SAA and CRP levels and ESR were significantly associated with Hurley staging in patients with HS (P = 0.03, P = 0.003, P = 0.02). Multivariate logistic regression analysis revealed that each unit increase in the ESR increased the HS risk by 1.08-fold (95% CI 1.02-1.13). HS is significantly associated with SAA, CRP, and ESR. Among these inflammatory parameters, ESR was an independent risk factor for HS. We recommend assessment of SAA, CRP, and ESR as biomarkers that reflect the disease severity in HS patients likely to develop complications.
Keywords: C-reactive protein; Erythrocyte sedimentation rate; Hidradenitis suppurativa; Serum amyloid A.
Similar articles
-
Visfatin and insulin levels and cigarette smoking are independent risk factors for hidradenitis suppurativa: a case-control study.Arch Dermatol Res. 2018 Dec;310(10):785-793. doi: 10.1007/s00403-018-1867-z. Epub 2018 Oct 6. Arch Dermatol Res. 2018. PMID: 30293125
-
Systemic inflammation correlates with depression and lower quality of life in patients with hidradenitis suppurativa independent of disease severity.Arch Dermatol Res. 2025 Mar 29;317(1):649. doi: 10.1007/s00403-025-04143-9. Arch Dermatol Res. 2025. PMID: 40156719
-
The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa.Mediators Inflamm. 2017;2017:2450401. doi: 10.1155/2017/2450401. Epub 2017 Jul 10. Mediators Inflamm. 2017. PMID: 28769536 Free PMC article.
-
Systematic review and meta-analysis of peripheral blood inflammatory markers in hidradenitis Suppurativa.J Dermatol. 2025 Apr;52(4):583-592. doi: 10.1111/1346-8138.17661. Epub 2025 Feb 7. J Dermatol. 2025. PMID: 39916653
-
Pathophysiology of hidradenitis suppurativa: An update.J Am Acad Dermatol. 2015 Nov;73(5 Suppl 1):S8-11. doi: 10.1016/j.jaad.2015.07.045. J Am Acad Dermatol. 2015. PMID: 26470623 Review.
Cited by
-
Serum Amyloid A: A Potential New Marker of Severity in Hidradenitis Suppurativa.Skin Appendage Disord. 2023 Jun;9(3):165-168. doi: 10.1159/000528658. Epub 2023 Feb 20. Skin Appendage Disord. 2023. PMID: 37325280 Free PMC article.
-
The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases.Pediatr Rheumatol Online J. 2022 Nov 24;20(1):106. doi: 10.1186/s12969-022-00757-9. Pediatr Rheumatol Online J. 2022. PMID: 36434581 Free PMC article.
-
Identification of Biomarkers and Critical Evaluation of Biomarker Validation in Hidradenitis Suppurativa: A Systematic Review.JAMA Dermatol. 2022 Mar 1;158(3):300-313. doi: 10.1001/jamadermatol.2021.4926. JAMA Dermatol. 2022. PMID: 35044423 Free PMC article.
-
Management of hidradenitis suppurativa in the inpatient setting: a clinical guide.Arch Dermatol Res. 2025 Jan 8;317(1):202. doi: 10.1007/s00403-024-03622-9. Arch Dermatol Res. 2025. PMID: 39777571 Free PMC article. Review.
-
What's Race Got to Do With It? CRP Levels in Immune Mediated Skin Diseases: Considerations for Hidradenitis Suppurativa.Front Immunol. 2022 Mar 29;13:847050. doi: 10.3389/fimmu.2022.847050. eCollection 2022. Front Immunol. 2022. PMID: 35432388 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous